Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

被引:331
作者
De Maria, R [1 ]
Zeuner, A
Eramo, A
Domenichelli, C
Bonci, D
Grignani, F
Srinivasula, SM
Alnemri, ES
Testa, U
Peschle, C
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Univ Catania, Ist Patol Gen, I-95124 Catania, Italy
[3] Ist Super Sanita, Dept Haematol & Oncol, I-00161 Rome, Italy
[4] Univ Perugia, Ist Med Interna & Sci Oncol, I-06122 Perugia, Italy
关键词
D O I
10.1038/46809
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The production of red blood cells follows the sequential formation of proerythroblasts and basophilic, polychromatophilic and orthochromatic erythroblasts, and is promoted by the hormone erythropoietin (Epo) in response to tissue hypoxia(1). However, little is known about the negative regulation of this process(2). Death receptors are a family of surface molecules that trigger caspase activation and apoptosis in a variety of cell types(3-5). Here we show that immature erythroid cells express several death receptors whose ligands are produced by mature erythroblasts. Exposure of erythroid progenitors to mature erythroblasts or death-receptor ligands resulted in caspase-mediated degradation of the transcription factor GATA-1, which is associated with impaired erythroblast development. Expression of a caspase-resistant GATA-1 mutant, but not of the wild-type gene, completely restored erythroid expansion and differentiation following the triggering of death receptors, indicating that there is regulatory feedback between mature and immature erythroblasts through caspase-mediated cleavage of GATA-1. Similarly, erythropoiesis blockade following Epo deprivation was largely prevented by the expression of caspase-inhibitory proteins or caspase-resistant GATA-1 in erythroid progenitors. Caspase-mediated cleavage of GATA-1 may therefore represent an important negative control mechanism in erythropoiesis.
引用
收藏
页码:489 / 493
页数:5
相关论文
共 28 条
  • [1] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [2] Caspases: the executioners of apoptosis
    Cohen, GM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
  • [3] Davis D, 1997, BRIT J RHEUMATOL, V36, P950
  • [4] Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis
    De Maria, R
    Testa, U
    Luchetti, L
    Zeuner, A
    Stassi, G
    Pelosi, E
    Riccioni, R
    Felli, N
    Samoggia, P
    Peschle, C
    [J]. BLOOD, 1999, 93 (03) : 796 - 803
  • [5] Apoptotic pathways: The roads to ruin
    Green, DR
    [J]. CELL, 1998, 94 (06) : 695 - 698
  • [6] Grignani F, 1998, CANCER RES, V58, P14
  • [7] Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival
    Gupta, P
    Niehans, GA
    LeRoy, SC
    Gupta, K
    Morrison, VA
    Schultz, C
    Knapp, DJ
    Kratzke, RA
    [J]. LEUKEMIA, 1999, 13 (01) : 44 - 53
  • [8] Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia
    Hasegawa, D
    Kojima, S
    Tatsumi, E
    Hayakawa, A
    Kosaka, Y
    Nakamura, H
    Sako, M
    Osugi, Y
    Nagata, S
    Sano, K
    [J]. BLOOD, 1998, 91 (08) : 2793 - 2799
  • [9] Inhibition of death receptor signals by cellular FLIP
    Irmler, M
    Thome, M
    Hahne, M
    Schneider, P
    Hofmann, B
    Steiner, V
    Bodmer, JL
    Schroter, M
    Burns, K
    Mattmann, C
    Rimoldi, D
    French, LE
    Tschopp, J
    [J]. NATURE, 1997, 388 (6638) : 190 - 195
  • [10] Krammer P H, 1999, Adv Immunol, V71, P163